14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
SENEB vs HLF: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, SENEB (SENEB) captures the overall head-to-head institutional edge over Herbalife Ltd. (HLF) on higher Unified Composite conviction (54.4/100 HOLD vs. 35.4/100 SELL) after splitting the core matrix 5–5 (led by Balance Sheet & Cash Flow), while HLF wins 5–1 across the 6-pillar growth and valuation breakdown. SENEB trades at $170.26 (48.1x Forward P/E, 8.9% operating margin) versus HLF at $16.15 (5.3x Forward P/E, 9.8% operating margin).
Growth vs. Quality Trade-Off: SENEB earns the overall head-to-head edge with a stronger Unified Composite Score (54.4/100 HOLD vs. HLF 35.4/100 SELL) and 0.10β · 88% Vol risk profile, whereas HLF leads top-line expansion (+6.0% YoY revenue growth, 0.61x PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SENEB vs HLF. Trailing 12-month operating profitability (SENEB 8.9% vs HLF 9.8%) and valuation multiples (SENEB 48.1x vs HLF 5.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Packaged Foods value chain with $1.7B market capitalization and 9.8% operating margin.
OpEx & R&D Reinvestment67.8% of Rev ($3.58B)
90D Engineering Disclosures0 Published
Investor FAQ SENEB vs HLF Key Questions & Quantitative Answers
As of Nov 16, 2026, SENEB (SENEB) captures the overall head-to-head institutional edge over Herbalife Ltd. (HLF) on higher Unified Composite conviction (54.4/100 HOLD vs. 35.4/100 SELL) after splitting the core matrix 5–5 (led by Balance Sheet & Cash Flow), while HLF wins 5–1 across the 6-pillar growth and valuation breakdown. SENEB trades at $170.26 (48.1x Forward P/E, 8.9% operating margin) versus HLF at $16.15 (5.3x Forward P/E, 9.8% operating margin). Growth vs. Quality Trade-Off: SENEB earns the overall head-to-head edge with a stronger Unified Composite Score (54.4/100 HOLD vs. HLF 35.4/100 SELL) and 0.10β · 88% Vol risk profile, whereas HLF leads top-line expansion (+6.0% YoY revenue growth, 0.61x PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.
HLF leads the Growth & Scale pillar: SENEB posts +7.1% YoY revenue growth and -0.4% YoY earnings growth on $1.80B TTM revenue (13.2% gross margin, 8.9% operating margin), compared with HLF at +6.0% YoY revenue growth and +31.5% YoY earnings growth on $5.28B TTM revenue (77.6% gross margin, 9.8% operating margin). On trailing 12-month operating scale, SENEB generates $1.80B in USD-normalized revenue versus $5.28B for HLF. In operating R&D and SG&A reinvestment, SENEB deploys 4.3% of Rev ($77M) (0 90-day corporate R&D disclosures) versus 67.8% of Rev ($3.58B) (0 disclosures) for HLF.
HLF screens cheaper on headline valuation multiples. SENEB trades at 48.1x Forward P/E, 10.0x Trailing P/E, 0.94x PEG, and 0.6x EV/Revenue (11.2% EBITDA margin), whereas HLF trades at 5.3x Forward P/E, 9.4x Trailing P/E, 0.61x PEG, and 0.6x EV/Revenue (6.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SENEB (16.1% ROE) versus HLF (0.0% ROE) capital efficiency.
In options market volatility and institutional positioning, SENEB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.10β · 88% Vol realized risk). By comparison, HLF carries 58.5% implied volatility (5th %ile, Compressed (<25th %ile)), a 0.21x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (1.06β · 47% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.